title: Enhanced cell death imaging using multivalent zinc(II)-bis(dipicolylamine) fluorescent probes.
abstract: There is a clinical need for imaging technologies that can accurately detect cell death in a multitude of pathological conditions. Zinc(II)-bis(dipicolylamine) (Zn2BDPA) coordination complexes are known to associate with the anionic phosphatidylserine that is exposed on the surface of dead and dying cells, and fluorescent monovalent Zn2BDPA probes are successful cell death imaging agents. This present study compared the membrane targeting ability of two structurally related deep-red fluorescent probes, bis-Zn2BDPA-SR and tetra-Zn2BDPA-SR, with two and four appended Zn2BDPA units, respectively. Vesicle and cell microscopy studies indicated that a higher number of Zn2BDPA targeting units improved probe selectivity for phosphatidylserine-rich vesicles, and increased probe localization at the plasma membrane of dead and dying cells. The fluorescent probes were also tested in three separate animal models, (1) necrotic prostate tumor rat model, (2) thymus atrophy mouse model, and (3) traumatic brain injury mouse model. In each case, there was more tetra-Zn2BDPA-SR accumulation at the site of cell death than bis-Zn2BDPA-SR. The results indicate that multivalent Zn2BDPA probes are promising molecules for effective imaging of cell death processes in cell culture and in living subjects.
authors.affiliation: Department of Chemistry and Biochemistry, 236 Nieuwland Science Hall, University of Notre Dame , Notre Dame, Indiana 46556, United States.
authors.forename: Bryan A
authors.initials: BA
authors.lastname: Smith
authors.forename: Kara M
authors.initials: KM
authors.lastname: Harmatys
authors.forename: Shuzhang
authors.initials: S
authors.lastname: Xiao
authors.forename: Erin L
authors.initials: EL
authors.lastname: Cole
authors.forename: Adam J
authors.initials: AJ
authors.lastname: Plaunt
authors.forename: William
authors.initials: W
authors.lastname: Wolter
authors.forename: Mark A
authors.initials: MA
authors.lastname: Suckow
authors.forename: Bradley D
authors.initials: BD
authors.lastname: Smith
mesh_terms: D000588:Amines / Q000737:chemistry*; D000818:Animals; D001930:Brain Injuries / Q000473:pathology; D016923:Cell Death / Q000502:physiology*; D002460:Cell Line; D003952:Diagnostic Imaging / Q000379:methods*; D005456:Fluorescent Dyes / Q000737:chemistry*; D006801:Humans; D008297:Male; D051379:Mice; D010848:Picolinic Acids / Q000737:chemistry*; D011471:Prostatic Neoplasms / Q000473:pathology; D051381:Rats; D013950:Thymus Gland / Q000473:pathology; D015032:Zinc / Q000737:chemistry*
chemical_list: C501847:2,2'-dipicolylamine; D000588:Amines; D005456:Fluorescent Dyes; D010848:Picolinic Acids; D015032:Zinc
references.citation: Arterioscler Thromb Vasc Biol. 2012 Jul;32(7):1552-62
references.pmid: 22596221
references.citation: Proc Natl Acad Sci U S A. 2011 Jul 12;108(28):11614-9
references.pmid: 21709226
references.citation: J Immunotoxicol. 2009 Dec;6(4):209-16
references.pmid: 19908939
references.citation: Chem Commun (Camb). 2009 Nov 14;(42):6329-38
references.pmid: 19841772
references.citation: Chembiochem. 2005 Dec;6(12):2214-20
references.pmid: 16276499
references.citation: Science. 1995 Mar 10;267(5203):1456-62
references.pmid: 7878464
references.citation: Biochem Pharmacol. 1992 Dec 1;44(11):2131-7
references.pmid: 1472078
references.citation: J Neurotrauma. 2004 Jun;21(6):733-40
references.pmid: 15253801
references.citation: Cell. 1999 Jan 22;96(2):245-54
references.pmid: 9988219
references.citation: Nature. 2010 Oct 14;467(7317):863-7
references.pmid: 20944749
references.citation: Oncogene. 2005 Nov 10;24(49):7381-8
references.pmid: 16044155
references.citation: J Clin Oncol. 1999 Sep;17(9):2941-53
references.pmid: 10561374
references.citation: J Cereb Blood Flow Metab. 2010 Aug;30(8):1477-86
references.pmid: 20197781
references.citation: Apoptosis. 2011 Jul;16(7):722-31
references.pmid: 21499791
references.citation: Org Biomol Chem. 2012 Aug 14;10(30):5769-73
references.pmid: 22159917
references.citation: Bioorg Med Chem Lett. 2012 Apr 15;22(8):2833-6
references.pmid: 22424976
references.citation: Bioconjug Chem. 2012 Oct 17;23(10):1989-2006
references.pmid: 22989049
references.citation: Curr Opin Chem Biol. 2004 Dec;8(6):617-25
references.pmid: 15556405
references.citation: Exp Mol Pathol. 2003 Oct;75(2):178-86
references.pmid: 14516782
references.citation: J Am Chem Soc. 2010 Jan 13;132(1):67-9
references.pmid: 20014845
references.citation: Prog Neurobiol. 1999 Feb;57(3):289-99
references.pmid: 10096842
references.citation: ACS Chem Neurosci. 2012 Jul 18;3(7):530-7
references.pmid: 22860222
references.citation: Mol Pharm. 2011 Apr 4;8(2):583-90
references.pmid: 21323375
references.citation: J Nucl Med. 2012 Nov;53(11):1659-62
references.pmid: 23033360
references.citation: J Leukoc Biol. 2007 Jan;81(1):6-14
references.pmid: 17005907
references.citation: Org Lett. 2010 Jan 1;12(1):140-3
references.pmid: 19957971
references.citation: Nat Rev Mol Cell Biol. 2000 Nov;1(2):120-9
references.pmid: 11253364
references.citation: Nat Commun. 2012 Jan 10;3:614
references.pmid: 22233624
references.citation: Immunity. 2011 Oct 28;35(4):445-55
references.pmid: 22035837
references.citation: Tetrahedron Lett. 2013 Feb 20;54(8):861-864
references.pmid: 23459472
references.citation: Angew Chem Int Ed Engl. 2007;46(29):5528-31
references.pmid: 17585399
references.citation: Immunopharmacology. 1994 Jul-Aug;28(1):55-66
references.pmid: 7523333
references.citation: Org Lett. 2005 Jul 7;7(14):3013-6
references.pmid: 15987193
references.citation: Bioconjug Chem. 2010 Jul 21;21(7):1297-304
references.pmid: 20536173